理研ビタミン株式会社 2026年3月期中間期決算補足資料

This document is a supplementary report on the interim financial results for the fiscal year ending March 2026 of RIKEN Vitamin Co., Ltd. For the interim period of fiscal year 2025, sales increased slightly compared to the previous year, but both operating and ordinary profits decreased. The domestic business saw an increase in profits due to reduced advertising expenses, while the overseas business suffered significant profit declines due to poor sales in China and intensified price competition. However, the net profit attributable to parent company shareholders increased due to the rebound from special losses incurred in the previous year. The future performance forecast anticipates growth in the domestic food business and a reassessment of sales strategies in overseas markets.